Screening compound: BUQIZDHWXQRUOL-GOSISDBHSA-N

Screening compound: BUQIZDHWXQRUOL-GOSISDBHSA-N
Screening compound: BUQIZDHWXQRUOL-GOSISDBHSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
BUQIZDHWXQRUOL-GOSISDBHSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D294-4188

Molecular Formula

C22H30N4O3 (C22 H30 N4 O3)

Compound Name

1-[2-(5-methyl-1H-indol-3-yl)ethyl]-N-[2-(morpholin-4-yl)ethyl]-5-oxopyrrolidine-3-carboxamide

IUPAC name

1-[2-(5-methyl-1H-indol-3-yl)ethyl]-N-[2-(morpholin-4-yl)ethyl]-5-oxopyrrolidine-3-carboxamide

SMILES

Cc(cc1)cc2c1[nH]cc2CCN(CC(C1)C(NCCN2CCOCC2)=O)C1=O

InChI

InChI=1S/C22H30N4O3/c1-16-2-3-20-19(12-16)17(14-24-20)4-6-26-15-18(13-21(26)27)22(28)23-5-7-25-8-10-29-11-9-25/h2-3,12,14,18,24H,4-11,13,15H2,1H3,(H,23,28)/t18-/m1/s1

InChI Key

BUQIZDHWXQRUOL-GOSISDBHSA-N

MDL Number (MFCD)

MFCD24851036

BUQIZDHWXQRUOL-GOSISDBHSA-N in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
  • Cyclic compounds
Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with BUQIZDHWXQRUOL-GOSISDBHSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound BUQIZDHWXQRUOL-GOSISDBHSA-N?
Check Price and Availability of BUQIZDHWXQRUOL-GOSISDBHSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of BUQIZDHWXQRUOL-GOSISDBHSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for BUQIZDHWXQRUOL-GOSISDBHSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for BUQIZDHWXQRUOL-GOSISDBHSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of BUQIZDHWXQRUOL-GOSISDBHSA-N available by request